Skip to main content
Clinical Trials/IRCT20210803052067N1
IRCT20210803052067N1
Completed
Phase 3

Evaluation of bone density changes before and after administration of at least one year of danozoomab in patients referred to Imam Reza Hospital

Artesh University of Medical Sciences0 sites202 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Artesh University of Medical Sciences
Enrollment
202
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Artesh University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Postmenopausal women (aged 45 to 75 years old) diagnosed with osteoporosis by densitometry via Dexa(dual energy Xray absorptiometry).

Exclusion Criteria

  • Lack of consent for being in the trial
  • Having hypersensitivity to denosumab or any component in the formulation
  • Malabsorption syndrome
  • History of thyroid surgery, parathyroid surgery or intestinal resection which has been caused malabsorption Patient

Outcomes

Primary Outcomes

Not specified

Similar Trials